Isturisa
These highlights do not include all the information needed to use ISTURISA safely and effectively. See full prescribing information for ISTURISA. ISTURISA (osilodrostat) tablets, for oral use Initial U.S. Approval: 2020
f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2
HUMAN PRESCRIPTION DRUG LABEL
Nov 3, 2023
Recordati Rare Diseases, Inc.
DUNS: 181699406
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Osilodrostat
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
Osilodrostat
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Osilodrostat
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
Osilodrostat
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
Osilodrostat
Product Details
FDA regulatory identification and product classification information